Neuromuscular disorders - Insights
Learn more about our specialized testing for neuromuscular diseases, including myasthenia gravis, Lambert-Eaton syndrome, and more.
Breast and Gynecological Cancer - Insights
Learn how our gynecological cancer and breast cancer treatment tests are designed to provide a detailed picture of a patient’s cancer diagnosis.
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.
Elevating accuracy of Alzheimer's testing - Insights
Learn how Mayo Clinic Laboratories Alzheimer’s disease testing provides clearer answers for more patients by offering the highest level of overall accuracy for the detection of amyloid pathology.
Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D. - Insights
Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating...
The Value Stream of an Outreach Program - Insights
When considering the outreach laboratory value stream, it is important to remember that without quality, there is no value. Through identifying sources for error or non-value-added activities, the hospital laboratory outreach program can...
Mass spectrometry-based assay detects viral antigens directly from clinical specimens - Insights
In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity...
Leveraging Lessons from the Past - Insights
Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.
Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.